- Most evidence comes from animal studies - Human data is extremely limited - No FDA approval for orthopedic use - Clinical benefit in musculoskeletal conditions remains unproven While the biology is interesting, potential does not equal proven clinical outcomes
Como hombre, siempre piensas que puedo hacer esto sin ayuda, que puedo ir al gimnasio y todas las dems mentiras que nos decimos a nosotros mismos
BPC-157 shows a lot of promise, and it comes up in conversations about peptides for injury recovery because of how it appears to behave
Since 1 June 2025 that authorisation should follow a face-to-face assessment
Put-GABA in addiction and psychiatric disease GABAergic IPSCs in striatal DA/GABA neurons are reduced by chronic but not acute alcohol exposure, and Put-GABA reduction in Aldh1a1 -knockout mice increases both ethanol consumption and ethanol preference in mice (Kim et al., 2015)
Stable Gastric Pentadecapeptide BPC 157-Possible Novel Therapy of Glaucoma and Other Ocular Conditions